Human agency in social cognitive theory.
A Bandura
https://pubmed.ncbi.nlm.nih.gov/2782727/Actively Recruiting
Led by Louise Reagan · Updated on 2025-07-28
128
Participants Needed
2
Research Sites
4 weeks
Total Duration
This research aims to evaluate the Diabetes LIVE JustICE application, designed to support diabetes self-management among formerly incarcerated individuals transitioning to supervised community housing. This group experiences a higher rate of diabetes and faces challenges such as limited diabetes knowledge, cognitive impairment, and restricted access to healthcare skills. The study uses a randomized clinical trial design with repeated assessments at 0, 6, and 12 weeks to examine feasibility, acceptability, and preliminary effects on behavior and clinical outcomes including glycemic control. Participants will be assigned to either the Diabetes LIVE JustICE intervention or a control group receiving enhanced pre-release diabetes education. The intervention group accesses a multi-user virtual environment via IOSAndroid mobile devices, offering real-time communication, instructor-led education, support sessions, and interactive resources over six weekly 1-hour sessions plus a support hour. The control group receives nurse-delivered diabetes education and literacy-tailored materials. The six-week series will be run multiple times over 18 months. During the study, participants will be monitored for recruitment, engagement, participation rates, and user experience. Assessments include diabetes knowledge, emotional distress, self-care behaviors, social support, perceived competence, and metabolic indicators like A1C. Focus groups will gather feedback on acceptability. Researchers will track changes from baseline through week 12, aiming to understand the interventions impact on diabetes management and support for this vulnerable population.
CONDITIONS
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
L
Lousie Reagan, PhD
S
Stephen Walsh, ScD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Louise Reagan
Lead Sponsor
American Diabetes Association
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Diabetes LIVE JustICE Virtual Environment | Enhanced Education (Active Comparator) |
|---|---|---|
| What it is | A virtual environment platform adapted for adults with diabetes reentering the community after incarceration, providing real-time interaction, instructor-led education sessions, access to digital resources, and opportunities for peer support. | A traditional enhanced diabetes education program provided to participants, offering structured educational materials and support as the active comparator. |
| Role in this trial | Investigational intervention being tested to support diabetes self-management during community reentry. | Active comparator arm, representing a current form of structured diabetes support and education. |
| Primary use | Designed to improve diabetes self-management skills, knowledge, emotional support, and peer communication using a virtual community. | Aims to provide education and structured support to improve diabetes knowledge and management through standard in-person or remote educational sessions. |
| How it is given or performed | Participants access the platform using a smartphone or computer, join real-time interactive sessions led by instructors, communicate with peers, and use digital resources within the virtual community. | Education is provided through scheduled sessions and distribution of educational materials, either in person or using traditional remote methods. |
| Evidence status | A feasibility study and early randomized trials in other populations suggest that virtual environments may improve diabetes knowledge and self-management, but there is not yet definitive outcome evidence in formerly incarcerated adults. | Strong evidence supports diabetes self-management education in improving glycemic control, emotional well-being, and self-care for adults with diabetes. |
| Important limitations | This virtual environment is in early testing, and its long-term impact and usability among formerly incarcerated adults are not yet established. Digital access and technology literacy may affect participation. | Traditional education depends on participant engagement, literacy, and opportunity to attend sessions. Barriers for participants reentering the community include access, time, and stigma. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 6 weeks
Participants receive diabetes self-management education and support through a mobile virtual environment or enhanced pre-release diabetes education.
Weekly synchronous 1-hour education sessions plus 1-hour support session
Duration - 6 weeks after treatment
Participants are monitored to assess the short-term effects of the intervention on diabetes knowledge, self-care, emotional distress, support, and metabolic indicators.
Assessments at week 12 (post-treatment)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
A Bandura
https://pubmed.ncbi.nlm.nih.gov/2782727/Emily H Thomas, Emily A Wang, Leslie A Curry...
https://pubmed.ncbi.nlm.nih.gov/27077019/Robin N Hunter Buskey, Kathleen Mathieson, Joan S Leafman...
https://pubmed.ncbi.nlm.nih.gov/26276137/Allison A Vorderstrasse, Gail D Melkus, Wei Pan...
https://pubmed.ncbi.nlm.nih.gov/26505161/G C Williams, Z R Freedman, E L Deci
https://pubmed.ncbi.nlm.nih.gov/9773724/Larisa M Strawbridge, Jennifer T Lloyd, Ann Meadow...
https://pubmed.ncbi.nlm.nih.gov/25616412/Rui Li, Sundar S Shrestha, Ruth Lipman...
https://pubmed.ncbi.nlm.nih.gov/25412060/Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian...
https://pubmed.ncbi.nlm.nih.gov/15817019/I M Stratton, A I Adler, H A Neil...
https://pubmed.ncbi.nlm.nih.gov/10938048/Michelle F Magee, Nawreen H Khan, Sameer Desale...
https://pubmed.ncbi.nlm.nih.gov/24557596/Louise Reagan
Lead Sponsor
American Diabetes Association
Collaborating Sponsor